Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Mid-term results of autograft and xenograft applications in hand enchondromas

Eyup Cagatay Zengin, Ahmet Savran, Hakan Ertem, Sertac Saruhan, Cumhur Davulcu, Muhittin Sener.




Abstract

Objectives: We evaluated the mid-term results of treatment with curettage followed by an autograft or xenograft application in patients with enchondroma of the hand.
Methods and Material: Between 2013-2017, 24 patients (13 males, 11 females; mean age 32 years; range 18-74 years) were operated for enchondroma of the hand. Following curettage of the lesion, reconstruction of the defect was made either by an autograft obtained from the iliac crest (n=16) or by a bovine xenograft (n=8). Functional and radiographic results were assessed according to the QDASH scoring system and the Tordai classification system, respectively.
Results: In the autograft group, the grafts were seen to be radiologically incorporated at mean five weeks (range, 4-6 weeks). In the functional results, the mean QDASH score was 2.4. No residual pain was determined in any patient, and all patients achieved full ROM. In the xenograft group, the grafts were seen to be radiologically incorporated at mean 16 weeks (range, 12-24 weeks). In the functional results, the mean QDASH score was 5.2. Non-union or recurrence was not determined in any patient of either group at the final follow-up examination.
Conclusion: Clinically similar successful results were seen in the treatment of enchondroma in hand using autograft or xenograft. Due to the limited resources of autograft and the high costs of the synthetic matrix, the option of xenograft seems to be more sustainable for orthopedic problems.

Key words: Bone graft, hand enchondroma, xenografting






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.